Stocktoria
BeOne Medicines Ltd. ONC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2016-03-02
BeOne Medicines Ltd. statistics & valuation
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 87.5% | 84.4% | 84.5% | 79.8% | 86.0% | — | — | — | — | — |
| Operating margin | 8.4% | -14.9% | -49.1% | -126.4% | -122.3% | -536.7% | -224.2% | -356.1% | -41.3% | -10940.2% |
| Net margin | 5.4% | -16.9% | -35.9% | -141.5% | -123.9% | -526.1% | -221.5% | -339.9% | -39.1% | -11141.8% |
| FCF margin | 17.6% | -16.6% | -69.9% | -128.7% | -132.8% | -453.6% | -196.1% | -311.8% | -14.1% | -10562.1% |
| Return on assets | 3.5% | -10.9% | -15.2% | -31.4% | -17.1% | -29.0% | -58.8% | -29.9% | -8.9% | -29.4% |
| Return on equity | 6.6% | -19.4% | -24.9% | -45.7% | -23.8% | -42.0% | -98.6% | -38.4% | -13.6% | -33.8% |
| Debt / equity | 0.22× | 0.05× | 0.06× | 0.05× | 0.03× | 0.05× | 0.09× | 0.02× | 0.01× | 0.05× |
| Current ratio | 3.41 | 1.80 | 2.32 | 3.55 | 4.76 | 4.61 | 3.78 | 7.89 | 6.09 | 10.68 |
Source: SEC EDGAR filings · CIK 0001651308 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.